This study aims to determine the expression of PAFR and ICAM–1in small airways and lung parenchymal areas mainly in type 2 pneumocytes and alveolar macrophages of patients with IPF compared to normal lungs to explain if IPF patients are more susceptible to infections. The gene discussed is PTAFR; the disease is infection.